Traws Pharma, Inc.

TRAW · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$13,081$21,338$16,886$20,821
Short-Term Investments$0$0$0$0
Receivables$1,323$1,765$18$18
Inventory$0$0$0$1,420
Other Curr. Assets$966$1,848$1,767$401
Total Curr. Assets$15,370$24,951$18,671$22,660
Property Plant & Equip (Net)$8$10$14$22
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$244$1$1$1
Total NC Assets$252$11$15$23
Other Assets$0$0$0$0
Total Assets$15,622$24,962$18,686$22,683
Liabilities
Payables$4,759$8,186$6,174$5,619
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$226$227$226
Other Curr. Liab.$2,593$3,121$3,509$3,375
Total Curr. Liab.$7,352$11,533$9,910$9,220
LT Debt$0$0$0$0
Deferred Rev, NC$0$2,565$2,677$2,791
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$8$42,494$111,619$0
Total NC Liab.$8$45,059$114,296$2,791
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$7,360$56,592$124,206$12,011
Equity
Pref Stock$0$0$0$0
Common Stock$71$36$253$210
Retained Earnings-$628,579-$649,154-$610,757-$482,631
AOCI$9-$42-$33-$23
Other Equity$636,761$617,530$505,017$493,116
Total Equity$8,262-$31,630-$105,520$10,672
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,622$24,962$18,686$22,683
Net Debt-$13,081-$21,338-$16,886-$20,821